Patients in Wales are to gain faster access to medicines recommended by NICE and Wales’ own cost-effectiveness body, the All Wales Medicines Strategy Group (AWMSG).
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
